192 related articles for article (PubMed ID: 26179105)
1. Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression.
Kocatürk B; Tieken C; Vreeken D; Ünlü B; Engels CC; de Kruijf EM; Kuppen PJ; Reitsma PH; Bogdanov VY; Versteeg HH
J Thromb Haemost; 2015 Sep; 13(9):1683-93. PubMed ID: 26179105
[TBL] [Abstract][Full Text] [Related]
2. Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner.
Kocatürk B; Van den Berg YW; Tieken C; Mieog JS; de Kruijf EM; Engels CC; van der Ent MA; Kuppen PJ; Van de Velde CJ; Ruf W; Reitsma PH; Osanto S; Liefers GJ; Bogdanov VY; Versteeg HH
Proc Natl Acad Sci U S A; 2013 Jul; 110(28):11517-22. PubMed ID: 23801760
[TBL] [Abstract][Full Text] [Related]
3. Interplay between alternatively spliced Tissue Factor and full length Tissue Factor in modulating coagulant activity of endothelial cells.
Ünlü B; Bogdanov VY; Versteeg HH
Thromb Res; 2017 Aug; 156():1-7. PubMed ID: 28570958
[TBL] [Abstract][Full Text] [Related]
4. Expression of flTF and asTF splice variants in various cell strains and tissues.
Pan L; Yu Y; Yu M; Yao S; Mu Q; Luo G; Xu N
Mol Med Rep; 2019 Mar; 19(3):2077-2086. PubMed ID: 30664196
[TBL] [Abstract][Full Text] [Related]
5. Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis.
Boltzen U; Eisenreich A; Antoniak S; Weithaeuser A; Fechner H; Poller W; Schultheiss HP; Mackman N; Rauch U
J Mol Cell Cardiol; 2012 May; 52(5):1056-65. PubMed ID: 22326437
[TBL] [Abstract][Full Text] [Related]
6. Expression and regulation of Cyr61 in human breast cancer cell lines.
Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
[TBL] [Abstract][Full Text] [Related]
7. Alternatively spliced tissue factor. A crippled protein in coagulation or a key player in non-haemostatic processes?
van den Berg YW; Versteeg HH
Hamostaseologie; 2010 Aug; 30(3):144-9. PubMed ID: 20680231
[TBL] [Abstract][Full Text] [Related]
8. Alternatively spliced tissue factor induces angiogenesis through integrin ligation.
van den Berg YW; van den Hengel LG; Myers HR; Ayachi O; Jordanova E; Ruf W; Spek CA; Reitsma PH; Bogdanov VY; Versteeg HH
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19497-502. PubMed ID: 19875693
[TBL] [Abstract][Full Text] [Related]
9. Activation of carbonic anhydrase IX by alternatively spliced tissue factor under late-stage tumor conditions.
Ramchandani D; Unruh D; Lewis CS; Bogdanov VY; Weber GF
Lab Invest; 2016 Dec; 96(12):1234-1245. PubMed ID: 27721473
[TBL] [Abstract][Full Text] [Related]
10. Splice variants of tissue factor promote monocyte-endothelial interactions by triggering the expression of cell adhesion molecules via integrin-mediated signaling.
Srinivasan R; Ozhegov E; van den Berg YW; Aronow BJ; Franco RS; Palascak MB; Fallon JT; Ruf W; Versteeg HH; Bogdanov VY
J Thromb Haemost; 2011 Oct; 9(10):2087-96. PubMed ID: 21812913
[TBL] [Abstract][Full Text] [Related]
11. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
Sengupta K; Banerjee S; Saxena N; Banerjee SK
Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
[TBL] [Abstract][Full Text] [Related]
12. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
13. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.
Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H
J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171
[TBL] [Abstract][Full Text] [Related]
14. Splice variants of Tissue Factor and integrin-mediated signaling.
Srinivasan R; Bogdanov VY
Thromb Res; 2012 May; 129 Suppl 2():S34-7. PubMed ID: 22425320
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of alternatively spliced tissue factor induces the pro-angiogenic properties of murine cardiomyocytic HL-1 cells.
Eisenreich A; Boltzen U; Malz R; Schultheiss HP; Rauch U
Circ J; 2011; 75(5):1235-42. PubMed ID: 21389637
[TBL] [Abstract][Full Text] [Related]
16. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.
Lazennec G; Katzenellenbogen BS
Mol Cell Endocrinol; 1999 Mar; 149(1-2):93-105. PubMed ID: 10375022
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines.
Pfeffer U; Fecarotta E; Arena G; Forlani A; Vidali G
J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):99-105. PubMed ID: 8603053
[TBL] [Abstract][Full Text] [Related]
18. Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma.
Unruh D; Turner K; Srinivasan R; Kocatürk B; Qi X; Chu Z; Aronow BJ; Plas DR; Gallo CA; Kalthoff H; Kirchhofer D; Ruf W; Ahmad SA; Lucas FV; Versteeg HH; Bogdanov VY
Int J Cancer; 2014 Jan; 134(1):9-20. PubMed ID: 23754313
[TBL] [Abstract][Full Text] [Related]
19. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
20. Cyr61 promotes breast tumorigenesis and cancer progression.
Tsai MS; Bogart DF; Castañeda JM; Li P; Lupu R
Oncogene; 2002 Nov; 21(53):8178-85. PubMed ID: 12444554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
